MilliporeSigma receives the industry's first EXCiPACT certification for cell culture media manufacturing

Ibex Medical Analytics achieves notable milestones with its AI-first approach to cancer diagnostics

Albertsons Companies pharmacies now offer COVID and flu vaccines to help protect communities this respiratory virus season

OmniSYS rebrands as XiFin Pharmacy Solutions, launches Pharmacy Payor Rate Transparency Monitor, and earns the Pharmacy 500 Award

Gilead’s Livdelzi (Seladelpar) receives FDA accelerated approval for primary biliary cholangitis

ProJenX announces the formation of its Clinical Advisory Board

Citius Pharmaceuticals' LYMPHIR™ wins FDA approval for relapsed/refractory cutaneous T-cell lymphoma

NewAmsterdam Pharma announces positive topline data from the Phase 3 BROOKLYN trial of Obicetrapib in heterozygous familial hypercholesterolemia patients

Cygnus Technologies and TriLink BioTechnologies® collaborate to launch AccuRes™ Host Cell DNA Quantification Kits

Neurocrine Biosciences Launches INGREZZA® SPRINKLE (valbenazine) Capsules.

Updated flu and COVID-19 vaccinations are now available at CVS Pharmacy® and MinuteClinic

$FDA Grants Second Approval for EPKINLY® (epcoritamab-bysp) to Treat Relapsed or Refractory Follicular Lymphoma$

FDA Grants Second Approval for EPKINLY® (epcoritamab-bysp) to Treat Relapsed or Refractory Follicular Lymphoma

Featured Press Releases

"Latigo Biotherapeutics has been granted FDA Fast Track Designation for LTG-001, a potential best-in-class Nav1.8 inhibitor for the non-opioid treatment of acute pain

Aadi Bioscience reports Q3 2024 financial results and updates on corporate progress

06 Nov 2024

Aadi Bioscience, Inc. announced financial results for the third quarter ended September 30, 2024,...

$Actinium Pharmaceuticals publishes Actimab-A + CLAG-M trial results for relapsed/refractory AML in Leukemia$

Actinium Pharmaceuticals publishes Actimab-A + CLAG-M trial results for relapsed/refractory AML in Leukemia

Sanguine Expands Oncology Biospecimen Portfolio via Strategic Clinic Partnerships

$ADC Therapeutics shares promising initial LOTIS-7 trial data on ZYNLONTA® combined with a bispecific antibody for relapsed/refractory DLBCL.$

ADC Therapeutics shares promising initial LOTIS-7 trial data on ZYNLONTA® combined with a bispecific antibody for relapsed/refractory DLBCL.

Quantum-Si launches Platinum® Pro, the end-to-end solution for gaining deeper insights in proteomics

ImmunoScape Appoints Peter Olagunju as Chief Executive Officer

By ImmunoScape Pte. Ltd.
ImmunoScape Pte. Ltd.
23 Sep 2026

LEVEL Relief Protab Reduced Everyday Aches and Pain in an Independent 29-Day Study

By LEVEL
LEVEL
22 Sep 2026

FDA Updates WINREVAIR™ Label with HYPERION Phase 3 Trial Data in Adults Newly Diagnosed with PAH

By Merck & Co., Inc.
Merck & Co., Inc.
22 Sep 2026

Padagis Expands Workplace Naloxone Access by Providing Free Nasal Sprays to Qualifying Businesses

By Padagis
Padagis
21 Sep 2026

StimCardio’s NeuroPulse Study Reports a Substantial Reduction in Recurrent Atrial Fibrillation Events Following Ablation Using Non-Invasive Wearable Neuromodulation

By StimCardio’s
StimCardio’s
21 Sep 2026

Bruker Receives Order for High-Field NMR Systems to Support a Major Upgrade of Magnetic Resonance Research Infrastructure at UC Berkeley.

By Bruker Corporation
Bruker Corporation
21 Sep 2026

Most Popular

Alamar Biosciences announces the launch of the NULISAqpcr™ AD 5-plex assay, advancing blood-based biomarker detection for Alzheimer’s disease research

By Alamar Biosciences, Inc.

Jan 13
Bruker complements fast and cost-effective IR Biotyper® hospital hygiene testing and HAI tracing with NGS reflex testing

By Bruker Corporation

Apr 11
Albertsons Companies pharmacies now offer COVID and flu vaccines to help protect communities this respiratory virus season

By Albertsons Companies

Aug 29

September 2026

M	T	W	T	F	S	S
	1	2	3	4	5	6
7	8	9	10	11	12	13
14	15	16	17	18	19	20
21	22	23	24	25	26	27
28	29	30

Search your requirement

Social media

MilliporeSigma receives the industry's first EXCiPACT certification for cell culture media manufacturing

Ibex Medical Analytics achieves notable milestones with its AI-first approach to cancer diagnostics

Albertsons Companies pharmacies now offer COVID and flu vaccines to help protect communities this respiratory virus season

OmniSYS rebrands as XiFin Pharmacy Solutions, launches Pharmacy Payor Rate Transparency Monitor, and earns the Pharmacy 500 Award

Gilead’s Livdelzi (Seladelpar) receives FDA accelerated approval for primary biliary cholangitis

ProJenX announces the formation of its Clinical Advisory Board

Citius Pharmaceuticals' LYMPHIR™ wins FDA approval for relapsed/refractory cutaneous T-cell lymphoma

NewAmsterdam Pharma announces positive topline data from the Phase 3 BROOKLYN trial of Obicetrapib in heterozygous familial hypercholesterolemia patients

Cygnus Technologies and TriLink BioTechnologies® collaborate to launch AccuRes™ Host Cell DNA Quantification Kits

Neurocrine Biosciences Launches INGREZZA® SPRINKLE (valbenazine) Capsules.

Updated flu and COVID-19 vaccinations are now available at CVS Pharmacy® and MinuteClinic

FDA Grants Second Approval for EPKINLY® (epcoritamab-bysp) to Treat Relapsed or Refractory Follicular Lymphoma

Featured Press Releases

"Latigo Biotherapeutics has been granted FDA Fast Track Designation for LTG-001, a potential best-in-class Nav1.8 inhibitor for the non-opioid treatment of acute pain

Aadi Bioscience reports Q3 2024 financial results and updates on corporate progress

Actinium Pharmaceuticals publishes Actimab-A + CLAG-M trial results for relapsed/refractory AML in Leukemia

Sanguine Expands Oncology Biospecimen Portfolio via Strategic Clinic Partnerships

ADC Therapeutics shares promising initial LOTIS-7 trial data on ZYNLONTA® combined with a bispecific antibody for relapsed/refractory DLBCL.

Quantum-Si launches Platinum® Pro, the end-to-end solution for gaining deeper insights in proteomics

ImmunoScape Appoints Peter Olagunju as Chief Executive Officer

LEVEL Relief Protab Reduced Everyday Aches and Pain in an Independent 29-Day Study

FDA Updates WINREVAIR™ Label with HYPERION Phase 3 Trial Data in Adults Newly Diagnosed with PAH

Padagis Expands Workplace Naloxone Access by Providing Free Nasal Sprays to Qualifying Businesses

StimCardio’s NeuroPulse Study Reports a Substantial Reduction in Recurrent Atrial Fibrillation Events Following Ablation Using Non-Invasive Wearable Neuromodulation

Bruker Receives Order for High-Field NMR Systems to Support a Major Upgrade of Magnetic Resonance Research Infrastructure at UC Berkeley.

Most Popular

Alamar Biosciences announces the launch of the NULISAqpcr™ AD 5-plex assay, advancing blood-based biomarker detection for Alzheimer’s disease research

Bruker complements fast and cost-effective IR Biotyper® hospital hygiene testing and HAI tracing with NGS reflex testing

Albertsons Companies pharmacies now offer COVID and flu vaccines to help protect communities this respiratory virus season

User Area

Discover

Engage with Us

Search your requirement

Social media

Featured Press Releases

Most Popular

User Area

Discover

Engage with Us

Subscribe to Our Monthly Newsletter